Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
05/2000
05/31/2000EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
05/31/2000EP1004323A1 Method for producing immunoglobulin preparations
05/31/2000EP1004311A1 Evacuant comprising magnesium oxide
05/31/2000EP1004303A1 Composition having capability of removing risk factor during exercise
05/31/2000EP1003899A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
05/31/2000EP1003894A2 Lentiviral vectors
05/31/2000EP1003787A2 Agent for the treatment and/or prophylaxis of microcirculation disorders
05/31/2000EP1003784A1 Novel peptides and polypeptides useful for regenerating the nervous system
05/31/2000EP1003543A1 Apoptosis-inducing gelsolin sequences
05/31/2000EP1003537A1 Et
05/31/2000EP1003534A1 Reovirus for the treatment of neoplasia
05/31/2000EP1003533A1 Use of herpes vectors for tumor therapy
05/31/2000EP1003532A1 Absorption of minerals by intestinal cells
05/31/2000EP1003527A1 Polynucleotide compositions
05/31/2000EP1003363A1 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(ERWINIA AMYLOVORA), ITS USE, AND ENCODING GENE
05/31/2000EP1003362A1 Hypersensitive response elicitor from erwinia amylovora and its use
05/31/2000EP0631619B1 Reconstituted cartilage tissue
05/31/2000CN1255163A Compounds
05/31/2000CN1255066A Plant extracts for the treatment of increase bone resorption
05/31/2000CN1254719A Defective adenovirus and its building-up method
05/31/2000CN1254582A Chinese patent medicine for treating rheumatic hyperosteogeny and its preparing process
05/31/2000CN1254581A Chinese patent medicine for treating cancers and unknown toxic swellings (subcutaneous ulcer and carbuncle) and its preparing process
05/31/2000CN1254562A Process for preparing exterior-applied medicine for treating psoriasis
05/31/2000CN1254561A Anticancer goose blood preparation
05/31/2000CN1254559A Broad-spectrum antibacterial medicine and its exterior application method
05/31/2000CN1052910C Granular medicine for curing sterility due to sperm antibody
05/31/2000CN1052907C Chinese herbal medicine for treating burn, skin and external diseases and preparing process thereof
05/31/2000CN1052904C Injection for curing cancer
05/31/2000CN1052890C Chinese proprietary medicine for curing headache and trigeminal neualagia
05/31/2000CN1052889C Chinese proprietary medicine for curing hepatitis
05/31/2000CN1052885C Chinese medicine herbs for giving off drug of opium
05/31/2000CN1052884C Traditional Chinese medicine Baiyuwan pill for treating vitiligo
05/31/2000CN1052883C Traditional Chinese medicine kexuanwan pill for treating psoriasis
05/31/2000CN1052882C Multipurpose inner coating agent for tooth
05/31/2000CN1052880C Method for preparation capsule for treating angioneurotic headache
05/31/2000CN1052879C Health-care medical wine
05/30/2000US6069138 Use of phospholipids of animal origin in therapy and/or dietetics
05/30/2000US6069134 Methods and compositions comprising DNA damaging agents and p53
05/30/2000US6069133 Targeted delivery of genes encoding interferon
05/30/2000US6069005 Hapatoblasts and method of isolating same
05/30/2000US6069001 Nucleotide sequence; for use in diagnosis of cancer and melanoma; for use in human leukocyte antigen typing for grafts and transplants
05/30/2000US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease
05/30/2000US6068837 Mesothelial cell gene therapy
05/30/2000US6068836 Providing a population of pluripotent hematopoetic cells, expanding population of stem cells to yield expanded stem cells, inducing a majority of cells in the population of expanded cells to become quiescent, using quiescent cells
05/30/2000CA2083333C High dosage topical forms of collagenase
05/25/2000WO2000029602A1 Transfection of male germ cells for generation of selectable transgenic stem cells
05/25/2000WO2000029601A1 A method for depopulating of vertebrate testis and for generation of transgenic species
05/25/2000WO2000029600A1 Systemic viral/ligand gene delivery system and gene therapy
05/25/2000WO2000029599A1 Viral vectors with late transgene expression
05/25/2000WO2000029564A2 Human glycine transporter type 2
05/25/2000WO2000029553A1 Bioengineered tissue constructs and methods for producing and using them
05/25/2000WO2000029552A1 Alginate layer system for chondrogenic differentiation of human mesenchymal stem cells
05/25/2000WO2000029551A2 Cells, culture methods, and their use in autologous transplantation therapy
05/25/2000WO2000029550A2 Low oxygen culturing of central nervous system progenitor cells
05/25/2000WO2000029549A2 Low oxygen culturing of cells
05/25/2000WO2000029443A1 Contraceptive antibody vaccines
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029426A1 Compositions and methods for controlling plant pests
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029029A1 Compositions and methods for producing vascular occlusion
05/25/2000WO2000029024A1 Formulation of adenovirus for gene therapy
05/25/2000WO2000029003A2 Method for preventing and reversing atherosclerosis in mammals
05/25/2000WO2000029002A2 In utero transplantation of human mesenchymal stem cells
05/25/2000WO2000029001A1 Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation
05/25/2000WO2000028947A2 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
05/25/2000WO2000028943A2 Selection and uses of lactic acid bacteria strains modulating non-specific immunity
05/25/2000WO2000016785A3 Humic acid and its use in the treatment of various conditions
05/25/2000WO2000015788A3 Dna sequence encoding oncofetal ferritin protein
05/25/2000WO2000008194A3 Cell lines for the propagation of mutated herpes viruses
05/25/2000WO2000000825A9 Detection and modulation of cellular immunity to immune privileged antigens
05/25/2000WO1999053949A9 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
05/25/2000WO1999026644A9 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
05/25/2000DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases
05/25/2000CA2351551A1 Low oxygen culturing of cells
05/25/2000CA2350917A1 Contraceptive antibody vaccines
05/25/2000CA2350890A1 Aqueous compositions for long-term stable storage of adenovirus particles including uses and methods for preparing same
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350782A1 Compositions and methods for controlling plant pests
05/25/2000CA2350698A1 Human glycine transporter type 2
05/25/2000CA2349919A1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
05/25/2000CA2349238A1 Systemic viral/ligand gene delivery system and gene therapy
05/25/2000CA2348824A1 12 human secreted proteins
05/25/2000CA2348781A1 Compositions and methods for producing vascular occlusion
05/25/2000CA2348599A1 Method for preventing and reversing atherosclerosis in mammals
05/25/2000CA2347914A1 Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation
05/24/2000EP1002859A1 Seeding of cells
05/24/2000EP1002539A1 Immunomodulator comprising bacterial cells or cell wall decomposition products thereof
05/24/2000EP1002538A2 Stem cell and lymphocyte storage
05/24/2000EP1002120A1 Chimeric adenoviral vectors
05/24/2000EP1002110A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
05/24/2000EP1002091A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
05/24/2000EP1002052A1 Novel lactic acid bacteria
05/24/2000EP1002051A2 PROBIOTIC STRAINS FROM $i(LACTOBACILLUS SALIVARIUS) AND ANTIMICROBIAL AGENTS OBTAINED THEREFROM
05/24/2000EP1001815A1 Vectors derived from antibodies for transferring substances into cells
05/24/2000EP1001807A1 Adoptive immunotherapy utilizing heat shock/stress protein-peptide complexes for prevention/treatment of cancer or infectious diseases
05/24/2000EP1001806A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
05/24/2000EP1001795A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene
05/24/2000EP1001794A1 Ratite extracts as therapeutic agents
05/24/2000EP1001675A1 Platelet suspensions and methods for resuspending platelets
05/24/2000EP0821590A4 Large area submucosal graft constructs and method for making the same
1 ... 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 ... 1259